Growth Metrics

Solid Biosciences (SLDB) Retained Earnings (2017 - 2024)

Solid Biosciences' Retained Earnings history spans 8 years, with the latest figure at $116000.0 for Q3 2024.

  • For Q3 2024, Retained Earnings rose 100.02% year-over-year to $116000.0; the TTM value through Sep 2024 reached $116000.0, up 100.02%, while the annual FY2023 figure was -$658.8 million, 17.06% down from the prior year.
  • Retained Earnings for Q3 2024 was $116000.0 at Solid Biosciences, up from -$708.1 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $116000.0 in Q3 2024 and bottomed at -$708.1 million in Q2 2024.
  • The 5-year median for Retained Earnings is -$404.6 million (2020), against an average of -$362.0 million.
  • The largest annual shift saw Retained Earnings crashed 40457000.0% in 2020 before it soared 100.02% in 2024.
  • A 5-year view of Retained Earnings shows it stood at -$404.6 million in 2020, then skyrocketed by 99.99% to -$45000.0 in 2021, then plummeted by 1250428.89% to -$562.7 million in 2022, then decreased by 17.06% to -$658.8 million in 2023, then soared by 100.02% to $116000.0 in 2024.
  • Per Business Quant, the three most recent readings for SLDB's Retained Earnings are $116000.0 (Q3 2024), -$708.1 million (Q2 2024), and -$683.1 million (Q1 2024).